Phase 2 Study of EPI-743 for Treatment of Rett Syndrome

NCT01822249 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Rett Syndrome

Interventions

DRUG: EPI-743
DRUG: Placebo

Sponsor

Edison Pharmaceuticals Inc